Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Illumina, Inc.
  6. News
  7. Summary
    ILMN   US4523271090

ILLUMINA, INC.

(ILMN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Illumina : To Discuss EU-Suggested Tweaks To Grail Acquisition

09/21/2021 | 01:14am EDT


ę MT Newswires 2021
All news about ILLUMINA, INC.
10/22INSIDER SELL : Illumina
MT
10/20ILLUMINA : to Host Inaugural ESG Investor Event on Tuesday, November 16, 2021
PR
10/20WALL STREET STOCK EXCHANGE : Earnings season, bitcoin and the metaverse
10/20ANALYST RECOMMENDATIONS : BHP Group, Cloudflare, Tesla, Microsoft, Target...
10/19ILLUMINA : SVB Leerink Adjusts Illumina's Price Target to $420 from $425, Keeps Market Per..
MT
10/15INSIDER SELL : Illumina
MT
10/15ILLUMINA : Ragusa succeeds Hans Bishop, who will continue to serve as Advisor to the CEO t..
PU
10/15Illumina, Inc. Announces Executive Changes
CI
10/15ILLUMINA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/15ILLUMINA : Appoints Bob Ragusa as GRAIL's CEO
MT
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
Financials (USD)
Sales 2021 4 344 M - -
Net income 2021 692 M - -
Net cash 2021 1 689 M - -
P/E ratio 2021 89,7x
Yield 2021 -
Capitalization 64 032 M 64 032 M -
EV / Sales 2021 14,4x
EV / Sales 2022 12,4x
Nbr of Employees 7 825
Free-Float 74,8%
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 409,15 $
Average target price 455,00 $
Spread / Average Target 11,2%
EPS Revisions
Managers and Directors
Francis A. deSouza President, Chief Executive Officer & Director
Sam A. Samad Chief Financial Officer & Senior Vice President
John Wendell Thompson Chairman
Phillip G. Febbo Chief Medical Officer
Alex Aravanis CTO, Head-Research & Product Development
Sector and Competitors
1st jan.Capi. (M$)
ILLUMINA, INC.10.58%64 032
THERMO FISHER SCIENTIFIC31.38%240 757
DANAHER CORPORATION41.07%223 934
INTUITIVE SURGICAL, INC.25.24%122 004
SIEMENS HEALTHINEERS AG40.64%77 031
EDWARDS LIFESCIENCES CORPORATION27.80%72 674